Multiple cytosolic DNA sensors bind plasmid DNA after transfection.


Journal

Nucleic acids research
ISSN: 1362-4962
Titre abrégé: Nucleic Acids Res
Pays: England
ID NLM: 0411011

Informations de publication

Date de publication:
04 11 2019
Historique:
accepted: 22 08 2019
received: 11 07 2019
pubmed: 10 9 2019
medline: 18 12 2019
entrez: 10 9 2019
Statut: ppublish

Résumé

Mammalian cells express a variety of nucleic acid sensors as one of the first lines of defense against infection. Despite extensive progress in the study of sensor signaling pathways during the last decade, the detailed mechanisms remain unclear. In our previous studies, we reported increased type I interferon expression and the upregulation of several proposed cytosolic DNA sensors after transfection of several tumor cell types with plasmid DNA (pDNA). In the present study, we sought to reveal the early events in the cytosolic sensing of this nucleic acid in a myoblast cell line. We demonstrated that DNA-dependent activator of interferon regulatory factors/Z-DNA binding protein 1 (DAI/ZBP1) bound plasmid DNA in the cytosol within 15 minutes of transfection and at consistent levels for 4 h. Interferon activated gene 204 protein (p204) and DEAH box helicase 9 (DHX9) also bound pDNA, peaking 15 and 30 min respectively. Plasmid DNA was not detectably bound by DEAD box helicase 60 (DDX60) protein, despite a similar level of mRNA upregulation to DAI/ZBP1, or by cyclic GMP-AMP synthase (cGAS), despite its presence in the cell cytosol. Taken together, these results indicate several DNA sensors may participate and cooperate in the complex process of cytosolic DNA sensing.

Identifiants

pubmed: 31495892
pii: 5565289
doi: 10.1093/nar/gkz768
pmc: PMC6821305
doi:

Substances chimiques

DNA-Binding Proteins 0
Dhx9 protein, mouse 0
Ifi16 protein, mouse 0
Interferon Type I 0
Nuclear Proteins 0
Phosphoproteins 0
RNA, Messenger 0
RNA-Binding Proteins 0
Zbp1 protein, mouse 0
DNA 9007-49-2
DDX60 protein, mouse EC 3.6.1.-
DEAD-box RNA Helicases EC 3.6.4.13

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

10235-10246

Subventions

Organisme : NCI NIH HHS
ID : R01 CA196796
Pays : United States

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of Nucleic Acids Research.

Références

PLoS One. 2011;6(6):e20923
pubmed: 21695134
J Pharm Sci. 2008 Feb;97(2):726-45
pubmed: 17823947
Cell. 2015 Jun 4;161(6):1293-1305
pubmed: 26046437
Cancer Gene Ther. 2010 Dec;17(12):864-71
pubmed: 20706286
Proc Natl Acad Sci U S A. 1999 Jan 19;96(2):709-14
pubmed: 9892698
Nat Immunol. 2010 Nov;11(11):997-1004
pubmed: 20890285
Immunity. 2006 Jan;24(1):93-103
pubmed: 16413926
Nucleic Acids Res. 1985 Feb 11;13(3):745-61
pubmed: 2582358
Annu Rev Immunol. 2002;20:709-60
pubmed: 11861616
PLoS One. 2017 Feb 9;12(2):e0171699
pubmed: 28182739
Mol Ther. 2013 Dec;21(12):2217-26
pubmed: 23941812
Nat Rev Immunol. 2012 Jun 22;12(7):479-91
pubmed: 22728526
Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):E62-71
pubmed: 24367117
Cancers (Basel). 2018 Jan 29;10(2):null
pubmed: 29382170
Nat Commun. 2017 Feb 10;8:14391
pubmed: 28186168
Biochim Biophys Acta. 2002 Jun 13;1563(1-2):23-8
pubmed: 12007621
Cancer Gene Ther. 2002 Apr;9(4):399-406
pubmed: 11960291
Immunity. 2013 May 23;38(5):870-80
pubmed: 23706668
Nucleic Acids Res. 2003 Jul 1;31(13):3651-3
pubmed: 12824386
Gene Ther. 2012 Mar;19(3):338-46
pubmed: 21716302
Nature. 2007 Jul 26;448(7152):501-5
pubmed: 17618271
Bioinformatics. 2002 Feb;18(2):333-4
pubmed: 11847087
Mol Ther. 2017 Mar 1;25(3):803-815
pubmed: 28129959
Trends Immunol. 2016 Feb;37(2):84-101
pubmed: 26755064
Mol Cell Biol. 2011 Sep;31(18):3802-19
pubmed: 21791617
Nature. 2016 Oct 12;538(7624):183-192
pubmed: 27734871
Mol Ther Nucleic Acids. 2016 Jun 07;5(6):e322
pubmed: 27271988
Nat Immunol. 2011 Sep 04;12(10):959-65
pubmed: 21892174
Proc Natl Acad Sci U S A. 2012 Jun 26;109(26):10558-63
pubmed: 22691496
Nucleic Acids Res. 2013 Jan;41(Database issue):D94-D100
pubmed: 23125372
FEBS Lett. 1996 Jul 8;389(3):225-8
pubmed: 8766704
Methods Enzymol. 1990;184:588-600
pubmed: 2388593
Nat Rev Genet. 2012 Mar 13;13(4):227-32
pubmed: 22411467
Proc Natl Acad Sci U S A. 2010 Aug 24;107(34):15181-6
pubmed: 20696886
Mol Ther Methods Clin Dev. 2014 Dec 17;1:14058
pubmed: 26052524
Nat Struct Biol. 2001 Sep;8(9):761-5
pubmed: 11524677
Immunobiology. 2013 Nov;218(11):1312-21
pubmed: 23962476
J Virol. 2012 Feb;86(4):1942-54
pubmed: 22171255
Int J Pharm. 2012 Feb 14;423(1):134-43
pubmed: 21601622
Bioorg Med Chem. 2003 Feb 6;11(3):459-64
pubmed: 12517441
Nat Immunol. 2006 Jan;7(1):40-8
pubmed: 16286919
Science. 2013 Feb 15;339(6121):786-91
pubmed: 23258413
Nat Immunol. 2016 Sep 20;17(10):1142-9
pubmed: 27648547
Cell Host Microbe. 2016 Nov 9;20(5):674-681
pubmed: 27746097
Nat Rev Immunol. 2015 Feb;15(2):87-103
pubmed: 25614319
Adv Drug Deliv Rev. 2008 Apr 29;60(7):847-57
pubmed: 18280611
Nat Rev Microbiol. 2016 Jun;14(6):360-73
pubmed: 27174148
Virology. 1993 Nov;197(1):303-11
pubmed: 8212566
Oncotarget. 2018 Apr 10;9(27):18665-18681
pubmed: 29721152
Sci Immunol. 2016 Aug 5;1(2):
pubmed: 27917412
J Immunol. 2011 Nov 1;187(9):4501-8
pubmed: 21957149
Mol Cell Biol. 2000 Sep;20(18):7024-36
pubmed: 10958697
J Virol. 2009 Nov;83(21):11356-66
pubmed: 19710149
Proc Natl Acad Sci U S A. 2008 Apr 8;105(14):5477-82
pubmed: 18375758
EMBO J. 1982;1(7):841-5
pubmed: 6329708
Nat Immunol. 2006 Feb;7(2):131-7
pubmed: 16424890
Nature. 1995 Apr 6;374(6522):546-9
pubmed: 7700380
EMBO J. 2017 Sep 1;36(17):2529-2543
pubmed: 28716805
Mol Ther. 2013 Apr;21(4):775-85
pubmed: 23164933
J Exp Med. 2017 Aug 7;214(8):2217-2229
pubmed: 28634194
Virology. 2015 May;479-480:146-52
pubmed: 25816762

Auteurs

Nina Semenova (N)

Frank Reidy Research Center for Bioelectrics, Old Dominion University, Norfolk, VA, USA.

Masa Bosnjak (M)

Department of Experimental Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.

Bostjan Markelc (B)

Department of Experimental Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.

Katarina Znidar (K)

Faculty of Health Sciences, University of Primorska, Izola, Slovenia.

Maja Cemazar (M)

Department of Experimental Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
Faculty of Health Sciences, University of Primorska, Izola, Slovenia.

Loree Heller (L)

Frank Reidy Research Center for Bioelectrics, Old Dominion University, Norfolk, VA, USA.
School of Medical Diagnostic and Translational Sciences, Old Dominion University, Norfolk, VA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH